1,688
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: GASTROINTESTINAL TUMORS

Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study

, , , , , , , , , , , , , , , & show all
Pages 923-930 | Received 20 Jan 2017, Accepted 03 Mar 2017, Published online: 04 Apr 2017

References

  • Yovino S, Poppe M, Jabbour S, et al. Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers. Int J Radiat Oncol Biol Phys. 2011;79:158–162.
  • van der Horst A, Wognum S, Dávila Fajardo R, et al. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2013;87:202–208.
  • van der Horst A, Lens E, Wognum S, et al. Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared. Int J Radiat Oncol Biol Phys. 2014;89:641–648.
  • Keall PJ, Starkschall G, Shukla H, et al. Acquiring 4D thoracic CT scans using a multislice helical method. Phys Med Biol. 2004;49:2053–2067.
  • Lens E, van der Horst A, Kroon PS, et al. Differences in respiratory-induced pancreatic tumor motion between 4D treatment planning CT and daily cone beam CT, measured using intratumoral fiducials. Acta Oncol. 2014;53:1257–1264.
  • Caravatta L, Macchia G, Mattiucci GC, et al. Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience. Radiat Oncol. 2014;9:198.
  • Yamazaki H, Nishiyama K, Tanaka E, et al. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. Anticancer Res. 2007;27:2965–2971.
  • Fokas E, Clifford C, Spezi E, et al. Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: analysis of the pretrial benchmark case for the SCALOP trial. Radiother Oncol. 2015;117:432–437.
  • Fokas E, Spezi E, Patel N, et al. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: analysis of the on-trial cases for the SCALOP trial. Radiother Oncol. 2016;120:212–216.
  • van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14:52–64.
  • Rasch CRN, Steenbakkers RJHM, Fitton I, et al. Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharynx cancer. Radiat Oncol. 2010;5:21.
  • Versteijne E, Gurney-Champion OJ, van der Horst A, et al. Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. Radiat Oncol. 2017;12:58.
  • Andreychenko A, Heerkens H, Meijer G, et al. SU-E-J-07: a functional MR protocol for the pancreatic tumor delineation. Med Phys. 2014;41:155–156.
  • Barral M, Taouli B, Guiu B, et al. Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology. 2015;274:45–63.
  • Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39:841–848.
  • Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 1999;43:57–66.
  • den Hartogh MD, Philippens MEP, van Dam IE, et al. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy. Radiat Oncol. 2014;9:63.
  • Dalah E, Moraru I, Paulson E, et al. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014;89:633–640.
  • Li J, Denniston KA, Hussain SM, et al. Comparison of CT and MRI-based gross tumor volume and organ at risk delineation for pancreatic cancer patients undergoing neoadjuvant stereotactic body radiation therapy. Int J Radiat Oncol. 2014;90:S356.
  • Versteijne E, van Eijck CHJ, Punt CJA, et al. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial. Trials. 2016;17:127.
  • Gurney-Champion OJ, Lens E, van der Horst A, et al. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Med Phys. 2015;42:2638–2647.
  • Steenbakkers RJHM, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a ‘Big Brother’ evaluation. Radiother Oncol. 2005;77:182–190.
  • Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol. 2009;54:2863–2873.
  • Hall WA, Mikell JL, Mittal P, et al. Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2013;86:102–107.
  • Gurney-Champion OJ, Nederveen AJ, Klaassen R, et al. Revisiting the potential of alternating repetition time balanced steady-state free precession imaging of the abdomen at 3 T. Invest Radiol. 2016;51:560–568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.